PRAS40 suppresses atherogenesis through inhibition of mTORC1-dependent pro-inflammatory signaling in endothelial cells.
Zhang KS, Schecker J, Krull A, Riechert E, Jürgensen L, Kamuf-Schenk V, Burghaus J, Kiper L, Cao Ho T, Wöltje K, Stangl V, Katus HA, Stangl K, Völkers M, Althoff TF.
Zhang KS, et al. Among authors: althoff tf.
Sci Rep. 2019 Nov 14;9(1):16787. doi: 10.1038/s41598-019-53098-1.
Sci Rep. 2019.
PMID: 31728028
Free PMC article.